Jay R. Luly, President and CEO at ENANTA PHARMACEUTICALS INC (ENTA), sold 15,000 shares at $35.35 ($530K) on 2015-02-20, disclosed to the SEC on 2015-02-20.
Scheduled sale ($530k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ENTA | SELL | 2024-12-10 | $41K | — | Filing → |
| ENTA | SELL | 2023-12-06 | $139K | — | Filing → |
| ENTA | SELL | 2023-03-14 | $2.5M | — | Filing → |